Skip to main content

Table 4 Distribution of 334 HIV/HBV co-infected patients on current anti-HBV treatment according to EACS treatment guidelines

From: Access to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of HIV/HBV co-infected patients in Italy

  EACS GC regimens EACS GU regimens
  n % n %
No indication for anti-HIV therapy 30 68.2 14 31.8
Indication for anti-HIV therapy° 202 79.2 53 20.8
Indication for anti-HIV therapy not known§ 2 -- -- --
Cirrhotic/HCC 21 65.6 11 34.4
Total 255 76.6 78 23.4
  1. EACS, European AIDS clinical society; GC, guideline consistent; GU, guideline unlisted; °according to EACS guidelines for HCV co-infection [6], 1 patient with triple HCV co-infection on PEG-IFN was considered as “consistent”; §3 patients: 2 on TDF plus LAM/FTC considered as “consistent”, 1 not classifiable.